Marker Therapeutics (MRKR) Return on Capital Employed Growth (5y) (2016 - 2026)
Marker Therapeutics (MRKR) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Marker Therapeutics |
28.20 Mn |
28.20 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
3,554.00 |
| Dec 31, 2025 |
5,495.00 |
| Sep 30, 2025 |
1,798.00 |
| Jun 30, 2025 |
206.00 |
| Mar 31, 2025 |
2,941.00 |
| Dec 31, 2024 |
3,080.00 |
| Sep 30, 2024 |
17,584.00 |
| Jun 30, 2024 |
18,149.00 |
| Mar 31, 2024 |
16,502.00 |
| Dec 31, 2023 |
39,065.00 |
| Sep 30, 2023 |
61,909.00 |
| Jun 30, 2023 |
86,642.00 |
| Mar 31, 2023 |
69,338.00 |
| Dec 31, 2022 |
20,569.00 |
| Sep 30, 2022 |
5,871.00 |
| Jun 30, 2022 |
5,257.00 |
| Mar 31, 2022 |
10,540.00 |
| Dec 31, 2021 |
5,097.00 |
| Sep 30, 2021 |
14,547.00 |
| Jun 30, 2021 |
-8,972.00 |
